Mirum Pharmaceuticals, Inc. - Common Stock (MIRM)

CUSIP: 604749101

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
51,400,915
Total 13F shares
57,251,922
Share change
+1,595,660
Total reported value
$4,197,137,135
Put/Call ratio
122%
Price per share
$73.31
Number of holders
268
Value change
+$132,883,151
Number of buys
160
Number of sells
90

Quarterly Holders Quick Answers

What is CUSIP 604749101?
CUSIP 604749101 identifies MIRM - Mirum Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q3 2025

As of 30 Sep 2025, Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) was held by 268 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 57,251,922 shares. The largest 10 holders included Frazier Life Sciences Management, L.P., JANUS HENDERSON GROUP PLC, BlackRock, Inc., VANGUARD GROUP INC, EVENTIDE ASSET MANAGEMENT, LLC, BVF INC/IL, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, NOVO HOLDINGS A/S, and TANG CAPITAL MANAGEMENT LLC. This page lists 268 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.